v3.26.1
Business Segments - Adjusted EBITDA (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Adjusted EBITDA        
Net sales $ 383,543 $ 347,825 $ 1,121,346 $ 917,518
Cost of goods sold 257,868 243,257 743,232 627,585
Selling, general and administrative expenses 81,022 71,053 231,875 213,186
Add: Depreciation and amortization 12,448 12,616 38,169 33,194
Add: Acquisition-related cost of goods sold   1,708 1,956 3,342
Subtract: Insurance proceeds   (1,546) (3,786) (2,803)
Adjusted EBITDA 78,463 72,221 248,828 184,423
Cost of Sales        
Adjusted EBITDA        
Add: Phibro Forward income growth initiatives implementation costs   3,798   3,798
Selling, General and Administrative Expenses        
Adjusted EBITDA        
Add: Phibro Forward income growth initiatives implementation costs 3,391 3,980 7,026 6,026
Animal Health        
Adjusted EBITDA        
Net sales 291,225 258,377 864,658 670,318
Add: Acquisition-related cost of goods sold   1,708 1,956 3,342
Subtract: Insurance proceeds   (1,546) (1,177) (2,803)
Adjusted EBITDA 71,103 63,123 228,144 161,684
Mineral Nutrition        
Adjusted EBITDA        
Net sales 73,418 66,774 205,351 189,086
Adjusted EBITDA 5,141 5,762 16,031 15,226
Performance Products        
Adjusted EBITDA        
Net sales 18,900 22,674 51,337 58,114
Adjusted EBITDA 2,219 3,336 4,653 7,513
Operating Segments        
Adjusted EBITDA        
Add: Depreciation and amortization 11,925 12,170 36,649 31,775
Operating Segments | Animal Health        
Adjusted EBITDA        
Cost of goods sold 176,315 166,221 517,218 412,547
Selling, general and administrative expenses 54,935 46,133 154,385 131,513
Add: Depreciation and amortization 11,128 11,369 34,310 29,318
Operating Segments | Animal Health | Cost of Sales        
Adjusted EBITDA        
Add: Phibro Forward income growth initiatives implementation costs   3,798   3,798
Operating Segments | Animal Health | Selling, General and Administrative Expenses        
Adjusted EBITDA        
Add: Phibro Forward income growth initiatives implementation costs   1,771   1,771
Operating Segments | Mineral Nutrition        
Adjusted EBITDA        
Cost of goods sold 66,838 59,562 185,337 169,804
Selling, general and administrative expenses 1,987 1,974 5,606 5,611
Add: Depreciation and amortization 548 524 1,623 1,555
Operating Segments | Performance Products        
Adjusted EBITDA        
Cost of goods sold 14,693 17,491 40,657 45,258
Selling, general and administrative expenses 2,237 2,124 6,743 6,245
Add: Depreciation and amortization $ 249 $ 277 $ 716 $ 902